Companies /Real Estate
Ventas Inc
NYSE: VTR Reit - Healthcare Facilities
$90.34
▲ $0.85 (+0.95%) today
Markets closed · 10:27pm ET

Ventas (VTR) Q3 2026 Earnings

Reported Oct 27, 2026, 4:32pm ET · SEC source
$0.13
Beat +18.18%
EPS · est. $0.11 GAAP
$1.8B
Beat +3.16%
Revenue · est. $1.8B
7 quarters
Consecutive EPS beats

How Did VTR Stock React to Q3 2026 Earnings?

% change · around the report
−6%−3%0Oct 27Oct 28report 4:32pm ETearnings−0.1%−0.9%
−6%−3%0Oct 27Oct 28earnings−0.1%−0.9%
VTR −0.9%S&P 500 −0.1%
−6%−3%0Oct 27Oct 28report 4:32pm ETearnings−0.5%−0.9%
−6%−3%0Oct 27Oct 28earnings−0.5%−0.9%
VTR −0.9%NASDAQ −0.5%
−4%0+4%Oct 26Nov 3report 4:32pm ETearnings−1.8%+4.4%
−4%0+4%Oct 26Nov 3earnings−1.8%+4.4%
VTR +4.4%S&P 500 −1.8%
−4%0+4%Oct 26Nov 3report 4:32pm ETearnings−4.6%+4.4%
−4%0+4%Oct 26Nov 3earnings−4.6%+4.4%
VTR +4.4%NASDAQ −4.6%
−2.72%
Day of report
+3.26%
Next session
+10.03%
One week

Did VTR Beat Earnings? Q3 2026 Results

Yes. Ventas reported Q3 2026 earnings of $0.13 a share on Oct 27, 2026, beating the $0.11 consensus estimate by 18.2%. Revenue was $1.8B against a $1.8B estimate.

Ventas, Inc. delivered a strong third quarter for fiscal 2026, beating Wall Street expectations on both the top and bottom lines and extending its consensus EPS beat streak to six consecutive quarters. The healthcare REIT posted GAAP earnings of $0.13 per diluted share, edging past the $0.11 consensus estimate by 18.18%, while revenue of $1.83 billion topped the $1.78 billion forecast by 3.16% and surged 23.0% year over year. The primary engine behind the quarter's outperformance was Ventas's Senior Housing Operating Portfolio, where same-store cash NOI climbed 16% year over year as U.S. average occupancy crossed 90% and revenue per occupied room grew 5%, reflecting robust demand tied to an aging U.S. population. Aggressive investment activity, with $5.20 billion in senior housing acquisitions completed year to date, further underpinned the results and prompted management to raise full-year 2026 guidance, now targeting normalized FFO per share of $3.87 to $3.90, alongside a higher net income per share range of $0.64 to $0.67, signaling continued confidence in the portfolio's growth trajectory.

Key Takeaways
  • SHOP Same-Store Cash NOI grew 16% YoY, led by U.S. growth of 17%
  • Same-Store RevPOR grew 5% YoY
  • Same-Store average occupancy grew 290 basis points YoY; U.S. SHOP average occupancy exceeded 90%
  • Same-Store Cash NOI margin expanded 190 basis points YoY from operating leverage
  • Total Company NOI grew 18% YoY and Total Company Same-Store Cash NOI grew 11% YoY
  • OM&R Same-Store Cash NOI grew 2.5% YoY
  • NNN Same-Store Cash NOI grew 8.4% YoY
  • Net Debt-to-Further Adjusted EBITDA improved to 4.4x from 5.3x a year ago

“Ventas delivered strong enterprise results and growth in the third quarter, as we executed our 1-2-3 strategy and drove outperformance at scale. Our large and growing Senior Housing Operating Portfolio powered the Company's organic property growth, and we used our differentiated platform, operating expertise and data advantages to generate results that significantly outperformed industry benchmarks.”

Ventas CEO, on the earnings call

What Is Ventas's Outlook?

Ventas raised its full-year 2026 guidance. Normalized FFO per share is now expected at $3.87–$3.90 (midpoint $3.89, representing 9–10% YoY growth), up from prior guidance of $3.85–$3.90. Attributable Net Income per share guidance was raised to $0.64–$0.67 from $0.58–$0.63. Nareit FFO per share is guided to $3.83–$3.86, up from $3.76–$3.81. The increase is primarily driven by accretive senior housing investment activity ($5.2 billion completed YTD vs. prior ~$4.5 billion expectation), partially offset by interest rate and foreign exchange impacts. Key assumptions include interest expense of ~$648 million at midpoint, disposition and loan repayment proceeds of ~$700 million at ~7% blended yield, FAD capital expenditures of ~$400 million, and a full-year weighted average diluted share count of 509 million.

VTR YoY Financials

Q3 2026 vs Q3 2025 · SEC filings Q3 2025 Q3 2026
$0$600.0M$1.2B$1.8B$1.5B$1.8BRevenue$66.0M$67.3MNet Income
$0$600.0M$1.2B$1.8BRevenueNet Income
VTR income statement, Q3 2026 versus Q3 2025
Metric Q3 2026 Q3 2025 Year over year
Revenue $1.8B $1.5B +23.0%
Net Income $67.3M $66.0M +1.9%

VTR Revenue by Segment

Senior Housing Operating Portfolio
Outpatient Medical and Research
Triple-Net Leased Properties

When Does Ventas Report Next?

Expected report date
After the close
Release timing

Figures from SEC filings and company reports. Not investment advice.